TREATMENT OF ADVANCED BREAST-CANCER WITH 20 MG TOREMIFENE, A PHASE-II STUDY - PRELIMINARY COMMUNICATION

被引：8
|
作者：
PYRHONEN, S
VALAVAARA, R
HEIKKINEN, M
RISSANEN, P
BLANCO, G
NORDMAN, E
HOLSTI, LR
HAJBA, A
机构：
[1] FARMOS GRP LTD,RES CTR,TURKU,FINLAND
[2] UNIV TURKU,CENT HOSP,DEPT RADIOTHERAPY & ONCOL,SF-20500 TURKU 50,FINLAND
[3] UNIV OULU,CENT HOSP,SF-90220 OULU 22,FINLAND
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90011-G
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Fourteen postmenopausal women with estrogen-receptor positive advanced breast cancer and no prior cytostatic treatment received 20 mg toremifene daily as a single dose after a loading dose (120→60→60 mg) for the first 3 days. All were evaluable and had undergone at least 6 weeks' treatment. Results were: no complete remissions (CR), 3 partial remissions (PR), 8 no change (NC) and 3 cases of progressive disease (PD). Three patients had mild side effects: nausea, insomnia, sweating and arm pain. © 1990.
引用
收藏
页码：227 / 228
页数：2
相关论文
共 50 条
  • [21] PHASE-II STUDY OF ANGUIDINE IN ADVANCED BREAST-CANCER
    YAP, HY
    MURPHY, WK
    DISTEFANO, A
    BLUMENSCHEIN, GR
    BODEY, GP
    CANCER TREATMENT REPORTS, 1979, 63 (05): : 789 - 791
  • [22] IDARUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    LIONETTO, R
    PRONZATO, P
    CONTE, PF
    SERTOLI, MR
    AMOROSO, D
    ROSSO, R
    CANCER TREATMENT REPORTS, 1986, 70 (12): : 1439 - 1440
  • [23] A PHASE-II STUDY OF MITOXANTRONE IN ADVANCED BREAST-CANCER
    PRONZATO, P
    ARDIZZONI, A
    CONTE, PF
    GULISANO, M
    LIONETTO, R
    REPETTO, L
    SCORNAVACCHE, V
    SERTOLI, MR
    ROSSO, R
    CHEMIOTERAPIA, 1986, 5 (03): : 150 - 153
  • [24] PHASE-II STUDY OF TENIPOSIDE IN ADVANCED BREAST-CANCER
    BOAS, J
    RASMUSSEN, D
    HANSEN, OP
    ENGELHOLM, SA
    DOMBERNOWSKY, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) : 463 - 464
  • [25] PHASE-II TRIAL OF SPIROGERMANIUM FOR TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER TREATMENT REPORTS, 1983, 67 (02): : 189 - 190
  • [26] AMSA AND PEPTICHEMIO IN THE TREATMENT OF ADVANCED METASTATIC BREAST-CANCER - A PHASE-II STUDY
    BUZDAR, AU
    LEGHA, SS
    HORTOBAGYI, GN
    POWELL, KC
    BLUMENSCHEIN, GR
    BODEY, GP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04): : 383 - 387
  • [27] PHASE-II STUDY OF ELLIPTINIUM ACETATE SALVAGE TREATMENT OF ADVANCED BREAST-CANCER
    ROUESSE, J
    SPIELMANN, M
    TURPIN, F
    LECHEVALIER, T
    AZAB, M
    MONDESIR, JM
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) : 856 - 859
  • [28] ELLIPTINIUM - PHASE-II STUDY IN ADVANCED MEASURABLE BREAST-CANCER
    TREAT, J
    GREENSPAN, A
    RAHMAN, A
    MCCABE, MS
    BYRNE, PJ
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 231 - 234
  • [29] PHASE-II STUDY OF VINDESINE IN PATIENTS WITH ADVANCED BREAST-CANCER
    WALKER, BK
    RAICH, PC
    FONTANA, J
    SUBRAMANIAN, VP
    ROGERS, JS
    KNOST, JA
    DENNING, B
    CANCER TREATMENT REPORTS, 1982, 66 (09): : 1729 - 1732
  • [30] A PHASE-II STUDY OF DOXIFLURIDINE IN PATIENTS WITH ADVANCED BREAST-CANCER
    ALBERTO, P
    JUNGI, WF
    SIEGENTHALER, P
    MERMILLOD, B
    OBRECHT, JP
    DECOSTER, G
    CAVALLI, F
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03): : 565 - 566
12345